Home › Sinovac Biotech Ltd. (SVA) Upgraded by Zacks Investment Research to "Hold"
 

Keywords :   


Sinovac Biotech Ltd. (SVA) Upgraded by Zacks Investment Research to "Hold"

2015-12-09 05:49:51| Biotech - Topix.net

According to Zacks, "Sonovac Biotech Ltd. specializes in the research, development, commercialization, and sales of human vaccines for infectious illnesses such as hepatitis A and hepatitis B, influenza, SARS, and avian flu. Sinovac is one of the leading emerging biotechnology companies in China.

Tags: to research hold investment

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09Eastern North Pacific Tropical Weather Outlook
28.09Atlantic Tropical Weather Outlook
28.09Post-Tropical Cyclone Helene Public Advisory Number 21
28.09Tropical Storm Joyce Public Advisory Number 5
28.09Summary for Tropical Storm Joyce (AT1/AL112024)
28.09Post-Tropical Cyclone Helene Public Advisory Number 21
28.09Tropical Storm Joyce Forecast Discussion Number 5
28.09Tropical Storm Joyce Wind Speed Probabilities Number 5
More »